Advertisement

Topics

Genetically Engineered T Cells Targeting MAGE-A3 Show Promise in Metastatic Cancer

11:40 EDT 24 Aug 2017 | Medscape

T cells genetically engineered to target the cancer germline antigen MAGE-A3 appear safe and effective in some patients with metastatic cancer, according to a study in 17 patients.
Reuters Health Information

Original Article: Genetically Engineered T Cells Targeting MAGE-A3 Show Promise in Metastatic Cancer

NEXT ARTICLE

More From BioPortfolio on "Genetically Engineered T Cells Targeting MAGE-A3 Show Promise in Metastatic Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...